vimarsana.com
Home
Live Updates
Aeromics and Simcere Announce the First-In-Human Dosing of C
Aeromics and Simcere Announce the First-In-Human Dosing of C
Aeromics and Simcere Announce the First-In-Human Dosing of Chinese Healthy Volunteers in Simcere's Phase I Study of The SIM0307 (AER-271), A New Drug for Brain Edema
/PRNewswire/ -- Simcere Pharmaceutical Group and Aeromics, Inc. today announced that Simcere dosed the first subjects in the SIM0307 (AER-271) Phase I study...
Related Keywords
China ,
Taiwan ,
United States ,
Hong Kong ,
Nanjing ,
Jiangsu ,
Macau ,
Chinese ,
Renhong Tang ,
Jinsheng Ren ,
Wang Yongjun ,
Mike Gresser ,
Lauren Beaney ,
Thomas Zindrick ,
Prnewswire Simcere Pharmaceutical Group ,
China National Medical Products Administration ,
Aeromics Inc ,
Simcere Pharmaceutical Group ,
Capital Medical University ,
Pharmaceutical Group ,
Beijing Tiantan ,
Professor Wang Yongjun ,
Beijing Tiantan Hospital ,
Chief Scientific Officer ,
Greater China ,
Executive Director ,
Executive Vice President ,
Aeromic Executive ,
Aeromics ,
Nc ,